Activin and Inhibin

Chloroquine Phosphate is an antimalarial agent that has been discovered to have a distinct affinity for melanin. Used in the treatment of arthritis, malaria and Lupus. Chloroquine Phosphate is a substrate of MRP.An antimalarial compound.

Chloroquine Phosphate is an antimalarial agent that has been discovered to have a distinct affinity for melanin. Used in the treatment of arthritis, malaria and Lupus. Chloroquine Phosphate is a substrate of MRP.An antimalarial compound.

Chloroquine Phosphate is an antimalarial agent that has been discovered to have a distinct affinity for melanin. Used in the treatment of arthritis, malaria and Lupus. Chloroquine Phosphate is a substrate of MRP.An antimalarial compound.

Cholesterol 24-hydroxylase-IN-1 (compound 17) is a potent, orally active, and highly selective cholesterol 24-hydroxylase (CH24H or CYP46A1) inhibitor ( IC 50 =8.5 nM). Cholesterol 24-hydroxylase-IN-1 can cross blood-brain barrier.Form:Solid.

Cholesterol 24-hydroxylase-IN-1 (compound 17) is a potent, orally active, and highly selective cholesterol 24-hydroxylase (CH24H or CYP46A1) inhibitor ( IC 50 =8.5 nM). Cholesterol 24-hydroxylase-IN-1 can cross blood-brain barrier.Form:Solid.

Cholesterol 24-hydroxylase-IN-1 (compound 17) is a potent, orally active, and highly selective cholesterol 24-hydroxylase (CH24H or CYP46A1) inhibitor ( IC 50 =8.5 nM). Cholesterol 24-hydroxylase-IN-1 can cross blood-brain barrier.Form:Solid.

Cholesterol 24-hydroxylase-IN-1 (compound 17) is a potent, orally active, and highly selective cholesterol 24-hydroxylase (CH24H or CYP46A1) inhibitor ( IC 50 =8.5 nM). Cholesterol 24-hydroxylase-IN-1 can cross blood-brain barrier.Form:Solid.

Chrysin 6-C-arabinoside 8-C-glucoside is a α±- glucosidase inhibitors which are widely used in the study for type 2 diabetes.

Chrysin 6-C-arabinoside 8-C-glucoside is a α±- glucosidase inhibitors which are widely used in the study for type 2 diabetes.

Chrysin 6-C-arabinoside 8-C-glucoside is a α±- glucosidase inhibitors which are widely used in the study for type 2 diabetes.

CI-1044 is an orally active PDE4 inhibitor with IC 50 s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5 , PDE4B2 , PDE4C2 and PDE4D3 , respectively.In VitroCI-1044 is an orally active PDE4 inhibitor with IC 50 s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5,

CI-1044 is an orally active PDE4 inhibitor with IC 50 s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5 , PDE4B2 , PDE4C2 and PDE4D3 , respectively.In VitroCI-1044 is an orally active PDE4 inhibitor with IC 50 s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5,